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Abstract 
Multidrug resistant organisms (MDROs) constitute a major public health threat globally. Clinical isolates of Pseu-
domonas aeruginosa remains one of the most studied MDROs however there is paucity of information regarding the 
susceptibility of its animal and plants isolates to antipseudomonas drug in Nigeria. From a total of 252 samples con‑
sisting of plants, animals and clinical samples, 54, 24 and 22 P. aeruginosa were isolated from vegetables, animals and 
clinical sources respectively. All the isolates were identified by standard biochemical methods. Antimicrobial suscepti‑
bility testing (AST) of the 100 P. aeruginosa isolates against 7 antipseudomonal drugs was carried out by disk diffusion 
method, the phenotypic detection of ESBL was done by double disk synergy test (DDST) while plasmid extraction 
on 20 selected isolates based on their resistance to 2 or more classes of antibiotics was carried out by alkaline lysis 
method and analysed with Lambda DNA/Hind lll marker respectively. The AST results revealed highest resistance of 
91 and 55 % to ceftazidime and carbenicillin respectively while highest susceptibilities of 99 % for piperacillin–tazo‑
bactam and imipenem were recorded in overall assay. Fifteen out of 100 isolates specifically (10) from vegetables, 
(3) clinical and (2) poultry isolates showed synergy towards the beta‑lactamase inhibitor indicating production of 
ESBL by DDST method. Detection of plasmids was among vegetable (n = 4), poultry (n = 4), cow (n = 3) and clinical 
isolates (n = 1). Plasmid profile for the selected isolates revealed 6 of the strains had one plasmids each while 5 strains 
possessed 2–4 plasmids and 1 strain had 5 plasmids. The sizes of the plasmid range from <1 to ≥23kbp. Detection 
of ESBL and Plasmids among the investigated isolates is suggestive of multiple interplay of resistance mechanism 
among the isolates. Plants and animal isolates of P. aeruginosa harbouring multiple mechanisms of resistance is of 
concern due to the danger it poses on the public health.
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Background
Antimicrobial resistance (AMR) among bacterial spe-
cies is now global public threat. AMR in bacteria is com-
monly associated with different resistant genes, transfer 
mechanisms, and antibiotic resistance reservoirs among 
different species. Indiscriminate use of antibiotics and 
prescriptions has been linked together as one of the 
instrumental factors leading to the emergence of multi-
drug resistant organisms (MDROs) in the community/
hospital (Bronzwaer et  al. 2002; Tarai et  al. 2013). Una-
bated spread and proliferation of AMR genes among 
pathogenic bacteria has regrettably been the cause of 
high morbidity and mortality among critically ill patients, 
and has been found to contribute substantially to rising 
cost of healthcare due to prolong admission and expen-
sive drugs for treatments annually (Carmeli et  al. 2002; 
Roberts et al. 2009).
The use of antibiotics in farming and livestock man-
agement has also contributed to the spread of antibiotic 
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resistance genes in the environment (Kümmerer 2004). 
In Agriculture, management of livestock and crop pro-
duction often involve the use antibiotics in form of con-
sumables that are usually excreted as biologically active 
metabolites in the environment. This can increase selec-
tive pressure and favours the growth of antibiotic resist-
ant strains of bacteria (Kümmerer 2004). Studies on 
bacteria isolated from raw vegetables sold in different 
markets and eateries, that are resistant to commercially 
available antibiotics have been documented previously 
(Bhutani et al. 2015; Nipa et al. 2011).
Other studies have also focused on incidence of pet, 
food processing and farm animals as reservoirs for anti-
biotic resistant bacteria (Barber et al. 2003; Guardabassi 
et al. 2004; Faldynova et al. 2008). Worthy of mention are 
documented reports of high incidence of AMR bacteria 
from poultry, cattle as well other food processing ani-
mals, which are frequently consumed (Faldynova et  al. 
2008; Ayeni et  al. 2016). It is also believed that health 
workers and families may serve as a conduit for the entry 
of resistance genes into the community and hospital 
environment where further spread into pathogen is pos-
sible (Molbak et al. 1999; Voss et al. 2005).
Pseudomonas aeruginosa is a Gram-negative, rod 
shaped; motile bacterium found abundant in various 
habitats and has been implicated in several human infec-
tions. Most P. aeruginosa infections are difficult to treat 
due to its ability to resist many structurally unrelated 
antibiotics, which is because of the presence of intrinsic 
and acquired antibiotic resistance mechanisms (Lister 
et  al. 2009). Antimicrobial drug resistance mechanisms 
and its acquisition in P. aeruginosa are remarkable, to the 
favour of the pathogen. Several mechanisms of resist-
ance to antimicrobial agents ranging from efflux pump to 
mobile genetic elements and hydrolysing enzymes have 
been described in clinical isolates of P. aeruginosa (Mesa-
ros et al. 2007; Odumosu et al. 2013, 2015a, b). Notably 
among these mechanisms is the production of various 
classes of β-lactamases that mediates their resistance to 
beta-lactam drugs. Over the last decades, enzymes in this 
category have been detected in P. aeruginosa, especially 
extended-spectrum beta-lactamase (ESBL) such as OXA, 
VEB, PER, SHV and TEM types of ESBL (Odumosu et al. 
2015; Mirsalehian et al. 2010).
Pseudomonas aeruginosa has been reported to account 
for up to 10 % of all human infections and is one of the 
important bacterial pathogens commonly isolated from 
various clinical and environmental samples (Rajat et  al. 
2012). It is also one of the major cause of diseases such 
as otitis, mastitis, endometritis, hemorrhagic pneu-
monia and urinary tract infections in both livestock 
and companion animals (Kidd et  al. 2011; Poonsuk and 
Chuanchuen 2012; Salomonsen et  al. 2013). However, 
in comparison with reported cases of hospital acquired 
infections, community associated infection due to P. 
aeruginosa is rarely reported (Huhulescu et al. 2011). Its 
ubiquity in the environment is with a high possible risk 
of plant-animal-human transfer of antimicrobial genes. 
However, due to the paucity of it’s the susceptibility from 
animals and plant origin to antispseudomonas drugs in 
Nigeria, a justification for this study was established. The 
objective of this study was to provide a snapshot of their 
resistance to antipseudomonas drug and production of 
ESBL. This will provide us a better understanding of how 
AMR are disperse in our environment and subsequently 
guide against it. For a good comparison, clinical isolates 
of P. aeruginosa from various samples were also included.
Methods
Between 2014 and 2015, from 252 samples comprising 
of 112 clinical samples, 82 vegetables, 41 cow dungs and 
17 poultry dungs, 100 consecutive and non-duplicated 
P. aeruginosa were randomly isolated of which 22 were 
obtained from clinical isolates, 54 from vegetables, 7 
from cows and 17 from poultry. These samples were col-
lected at different farms, hospitals at different geographi-
cal locations across south-western Nigeria states making 
these isolates to have different epidemiological relation-
ships. All samples were obtained by informed consent 
of the patients in this study, proper ethical clearance 
approval was obtained from Babcock University Health 
Research Ethics committee NHREC/17/12/2013.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed and 
interpreted according to the Clinical Laboratory Stand-
ard Guidelines 2010 (CLSI 2010) on Mueller–Hinton 
agar (Oxoid UK) for 7 antibiotics: piperacillin–tazobac-
tam (100/10  µg), cefepime (30  µg) imipenem (10  µg), 
amikacin (30  µg), ciprofloxacin (5  µg), carbenicillin 
(100 µg) and ceftazidime (30 µg) (OXOID UK). P. aerugi-
nosa ATCC 27853 and E. coli ATCC 25922 were used as 
quality control.
Phenotypic detection of ESBL by double‑disk synergy test 
method (DDST)
A modified method for DDST (Jarlier et  al. 1988), was 
performed for all the beta-lactam-resistant and interme-
diate resistant strains as a standard disk diffusion assay 
on Mueller–Hinton agar. A 0.5 Mac Farland standard 
suspension of the test bacteria were evenly inoculated 
on the Mueller–Hinton agar by gentle swabbing using 
sterile swabbing sticks. Disks containing 30 μg of aztre-
onam, ceftazidime, and cefepime, were placed 20  mm 
apart (centre to centre) consecutively from piperacillin/
tazobactam (110 μg) and incubated for 18–24 h at 37 °C. 
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Enhancement of the inhibition zone towards the piper-
acillin–tazobactam disc, indicating synergy between 
piperacillin–tazobactam and any one of test antibiotics, 
was regarded as presumptive ESBL production. Kleb-
siella pneumoniae ATCC 700603 and Escherichia coli 
ATCC 25922 were used for positive and negative controls 
respectively.
Plasmid isolation and profiling
Plasmids DNA for selected ESBL positives and multidrug 
resistance strains totaling 20 was performed as described 
Kado and Liu (Kado and Liu 1981). Briefly, bacterial cul-
tures from Mueller–Hinton broth were suspended in 
microcentrifuge tubes with lysis buffer, the suspension 
was heated for 15 min at 70 °C and mixed with an equal 
volume of phenol:chorophorm:isoamyl alcohol (25:24:1) 
for plasmid extraction. The supernatants were loaded on 
a 1 % agarose gel in Tris–acetate–EDTA buffer and run 
for an hour at 80  V. The representative plasmids were 
digested with EcoRI while Lambda DNA/HindIII marker 
was used for molecular size estimation by comparing 
their motilities on agarose gel with the marker. The DNA 
bands were visualized and photographed by using Gel 
Documentation system after staining with gel red and 
with UV transillumination.
Statistical analysis
The Chi square test was used to compare the difference 
in the prevalence of isolates recovered from the various 
categories of samples at significant level, α = 5 %.
Result
Pseudomonas aeruginosa distribution among the samples 
collected is as follows; poultry 100  %, vegetables  54/82 
(66  %), clinical isolates 22/112 (19.6  %) and cow dungs 
7/41 (17  %), The results of the antimicrobial suscepti-
bility testing for P. aeruginosa shows a high-level resist-
ance (100  %) to ceftazidime among clinical and animal 
isolates, while vegetable isolates showed 45 (83.3  %) 
resistance (Tables 1, 2, 3, 4, 5). The overall susceptibility 
studies show 55 and 91 % isolates were resistant to car-
benicillin and ceftazidime respectively. The susceptibili-
ties of the isolates to imipenem, piperacillin–tazobactam, 
cefepime, ciprofloxacin and amikacin were 99, 99, 98, 
96 and 88 % respectively. Phenotypic detection of ESBL 
among the P. aeruginosa isolates was confirmed in 15 of 
100. Accordingly, a total percentage of 43 positive ESBL 
was detected in overall, this comprised of 18  % (10/54) 
from vegetables, 13 % (3/22) from clinical and 12 % (2/17) 
from poultry isolates. ESBL was detected at the 25  mm 
distance synergy towards cefepime and aztreonam in all 
the isolates. Plasmid profiles for the selected 20 isolates 
are represented in Table  6. Twelve isolates harboured 
multiple plasmids of copies ranging from 1 to 5 and esti-
mated size ranges of < 1 to ≥ 23 (kbp). Highest number 
of plasmids 4 (33.33  %) were detected from vegetables 
and poultry isolates, 3 (25 %) was detected in cow while 
only 1 (8.33  %) was detected in clinical isolates. All the 
isolates harbouring plasmids were resistant to carbenicil-
lin and ceftazidime but shows complete susceptibilities to 
cefepime, imipenem, and piperacillin–tazobactam antibi-
otics. Statistical analysis shows no significant difference 
in the prevalence of isolate recovered from the various 
categories at α = 5 % significant level.     
Discussion
The result of the investigation in this study has revealed 
the various distribution of P. aeruginosa across the sam-
ples indicative of the pathogen ubiquity especially in the 
environment. A high count of P. aeruginosa was found in 
ready to eat vegetables than those isolated from animal 
and human sources. Similar isolation of high prevalence 
of P. aeruginosa from vegetables has been previously 
reported (Oluyege et  al. 2015; Sabry et  al. 2011). Pres-
ence of P. aeruginosa in animal faeces that is intentionally 
used as fertilizers or unintentionally in form of droppings 
from free-range animals in the soil suggests a possible 
source of contamination of the raw vegetables as well as 
Table 1 Antibiotic resistance patterns of the 54 P. aeruginosa isolates from ready to eat vegetables in percentage distri-
bution
Type of antibiotic No (%) of resistant No (%) of intermediate No (%) of susceptible
Carbenicillin (100 µg) 34 (63.0) 6 (11.11) 14 (25.9)
Amikacin (30 µg) 1 (1.9) 4 (7.4) 49 (90.7)
Ceftazidime (30 µg) 45 (83.3) – 9 (16.7)
Cefepime (30 µg) – – 54 (100)
Ciprofloxacin (5 µg) – – 54 (100)
Imipenem (10 µg) – – 54 (100)
Piperacillin–Tazobactam (110 µg) – – 54 (100)
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the hands of sellers or water used in washing the food 
substances. Clinical isolates of P. aeruginosa recovered in 
the samples were lower in comparison to the number of 
samples collected. Even though P. aeruginosa is ubiqui-
tous, the prevalence of its isolation among animal isolates 
in this study was lower compared to other general such 
Table 2 Antibiotic resistance patterns of the 7 P. aeruginosa isolates from cow
Type of antibiotic No (%) of resistant No (%) of intermediate No (%) of susceptible
Carbenicillin (100 µg) 3 (42.9) 1 (14.2) 3 (42.9)
Amikacin (30 µg) – – 7 (100)
Ceftazidime (30 µg) 7 (100) – –
Cefepime (30 µg) – – 7 (100)
Ciprofloxacin (5 µg) – – 7 (100)
Imipenem (10 µg) – – 7 (100)
Piperacillin–Tazobactam (110 µg) – – 7 (100)
Table 3 Percentage distribution of antibiotic resistance patterns of the 17 P. aeruginosa isolates from poultry
Type of antibiotic No (%) of resistant No (%) of intermediate No (%) of susceptible
Carbenicillin (100 µg) 14 (82.4) – 3 (17.6)
Amikacin (30 µg) 3 (17.6) 2 (11.8) 12 (70.6)
Ceftazidime (30 µg) 17 (100) – –
Cefepime (30 µg) – – 17 (100)
Ciprofloxacin (5 µg) – – 17(100)
Imipenem (10 µg) – – 17 (100)
Piperacillin–Tazobactam (110 µg) – – 17 (100)
Table 4 Percentage distribution of antibiotic resistance patterns of 22 clinical P. aeruginosa isolates
Type of antibiotic No (%) of resistant No (%) of intermediate No (%) of susceptible
Carbenicillin (100 µg) 4 (18.2) 5 (22.7) 13 (59.1)
Amikacin (30 µg) 2 (9.1) – 20 (90.9)
Ceftazidime (30 µg) 22 (100) – –
Cefepime (30 µg) 1 (4.55) 1 (4.55) 20 (90.9)
Ciprofloxacin (5 µg) 4 (18.2) – 18 (81.8)
Imipenem (10 µg) 1 (4.5) – 21 (95.5)
Piperacillin–Tazobactam (110 µg) 1 (4.5) – 21 (95.5)
Table 5 Antibiotic resistance patterns of the 100 Pseudomonas aeruginosa isolates in percentage distribution
Type of antibiotic No (%) of resistant No (%) of intermediate No (%) of susceptible
Amikacin (30 µg) 6 6 88
Carbenicillin (100 µg) 55 12 33
Ceftazidime (30 µg) 91 – 9
Cefepime (30 µg) 1 1 98
Ciprofloxacin (5 µg) 4 – 96
Imipenem (10 µg) 1 – 99
Piperacillin–tazobactam (110 µg) 1 – 99
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as Enterococci and Escherichia which are commonly 
encountered and as previously reported from other stud-
ies (Ayeni et al. 2016; Ojo et al. 2013).
Comparing the sensitivity patterns of the isolates recov-
ered from the three sources, it was observed that isolates 
from poultry showed highest number of resistance to cef-
tazidime and carbenicillin, the two most resisted antip-
seudomonas drug in this study. Amikacin resistance and 
intermediate susceptibility among poultry isolates were 
also highest (29.4 %) compared to all other sources. The 
observed high resistance by poultry isolates in this study 
suggest the possibility of selective pressure developed as 
a result of antibiotic use in management of poultry. It has 
been previously reported that food processing animals 
especially poultry serves as reservoirs for antibiotic resist-
ance genes due to antibiotic use in poultry management 
(Diarrassouba et al. 2007; Mena et al. 2008). Such use of 
drugs is less common in the management of cattle and 
vegetable propagation because cattle rearing in Nigeria is 
largely carried out by local herdsman in a nomadic fashion 
with little or no education on the use of growth promo-
tion in livestock business (Author’s personal observation).
In the present study, 100 % susceptibilities to ciproflox-
acin, cefepime, imipenem and piperacillin/tazobactam 
was observed among the plants and animal P. aeruginosa 
isolates. This is in agreement with a recent study from 
France where a high proportion of the P. aeruginosa iso-
lates from cattle and horse were susceptible to similar 
antibiotics as reported in this study (Marisa et al. 2015). 
However among the clinical isolates, there were pock-
ets of resistance to cefepime, imipenem and piperacil-
lin/tazobactam at 4.5 % each, while 18.2 % of the isolates 
showed resistance to ciprofloxacin suggesting the fre-
quent use of these antibiotics clinically may play a signifi-
cant role in its increasing resistance.
The phenotypic detection of ESBL among the isolates 
in this study was carried out with a modified method by 
including a fourth generation cephalosporin (cefepime) 
and tazobactam as the beta-lactamase inhibitor. 
Cefepime is resistant to the production of AmpC beta-
lactamase commonly produced among P. aeruginosa 
that always mask the detection of ESBL phenotypically 
(Tzelepi et  al. 2000). Previous studies have documented 
tazobactam inhibitory activity against ESBL and AmpC 
beta-lactamase to be almost tenfold greater than clavu-
lanic acid (Bush et al. 1993; Phillippon et al. 2002).
Out of 100 isolates investigated for ESBL phenotypi-
cally, 15  % of the isolates were positive with synergies 
towards cefepime. This result is higher than observed fre-
quency of 4.0 and 8.1 % reported from Turkey and Iran 
respectively (Gençer et  al. 2002; Tavajjohi et  al. 2011) 
but is in contrast with two previous Nigerian studies that 
reported higher frequencies of ESBL in P. aeruginosa 
(Aibinu et al. 2007; Akinjogunla et al. 2010) although per-
centages sometimes is a reflection of the population of 
the study sample hence in essence may not reflect higher 
or lower proportion perse (Figs. 1, 2). 
In the present study, high resistance to third genera-
tion cephalosporin (ceftazidime) and carboxypenicillins 
(carbenicillin) both of beta-lactam class of antibiotics is 
worrisome. Ninety-one percent (91  %) of the P. aerugi-
nosa investigated from clinical, animal and plant sources 
were resistant to ceftazidime in this study while 55 % were 
resistant to carbenicillin. According to previous studies, 
resistance to ceftazidime and carbenicillin by P. aerugi-
nosa is mostly due to the presence of extended-spectrum 
beta-lactamases such as OXA types and PER that are com-
monly detected in P. aeruginosa and are usually encoded 
on mobile genetic elements such as plasmids and inte-
grons (Odumosu et  al. 2013, 2015; Alikhani et  al. 2014). 
Table 6 Plasmid distribution among the isolates
Isolate code No of plasmid Plasmid profile kilobase pair (kbp) Source of isolate Resistance pattern
P8 5 <1, <2, 2, >2, ≥23 Poultry CAR, CAZ, AK
S5 4 <1, ≤1, <2, ≥ 23 Vegetables CAR, CAZ, AK
MU2 4 <1, ≤1, <2, ≥23 Vegetables CAR, CAZ, AK
C23 2 <2, ≥23 Cow CAR, CAZ
3L 2 <2, ≥23 Clinical CAR, CAZ
C21 2 <2, ≥23 Cow CAR, CAZ
S3 1 ≥23 Vegetables CAR, CAZ, AK
P14 1 ≥23 Poultry CAR, CAZ
P16 1 ≥23 Poultry CAR, CAZ, AK
C18 1 ≥23 Cow CAR, CAZ, AK
P6 1 ≥23 Poultry CAR, CAZ, AK
MU1 1 ≥23 Vegetables CAR, CAZ, AK
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Interestingly the P. aeruginosa investigated in this study for 
the presence of plasmids all had diverse plasmids profile 
with copies ranging from 1 to 5 and estimated size ranges 
of <1 to ≥23 (kbp) (Table 6). Plasmids are mobile genetic 
elements and can also facilitate the dispersal of resistance 
genes among the bacterial population and can also serve as 
vehicle for other resistance mechanisms. Although the pre-
sent study did not investigate the association of plasmids 
with the observed resistance, previous studies have shown 
plasmids with capacity for multiple resistance to antimicro-
bial agents. Incidence of these genes in animal and plants 
for human consumption is dangerous because of the risk 
of transmission of resistant strains from animal origin to 
humans. Cattles and poultry are frequently consume in 
Nigeria as part of normal diet and some people eat roasted 
chicken and beef without proper boiling to kill all the avail-
able pathogen. This may lead to serious public health haz-
ard if such animal or plant sources are consumed.
Conclusion
The present study provides a view into the antibiotic sus-
ceptibility profile of P. aeruginosa isolated from plants 
animals and humans to antipseudomonas drugs. The 
multiplicity of antibiotic resistance, detection of ESBL 
and plasmids among the isolates in this study is disturb-
ing considering the fact that it establishes their potential 
abilities to the spread of antimicrobial resistance. The 
abundance MDROs from animal and plants in this study 
suggests that risk of human susceptibility to AMR bac-
teria from these sources is plausible. Although this study 
did not provide a direct evidence of their link and to what 
extend these sources contribute to AMR in comparison to 
clinical sources and hospital environments. Urgent meas-
ures are necessary to restrict the continuous abuse of anti-
biotics especially in livestock production. Further studies 
will be carried out in continuation, to fill the pending gaps 
in this study such as recognizing the relationship between 
the AMR bacteria from the animals and humans.
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Fig. 1 ESBL detection using DDST with piperacillin/tazobactam as 
beta‑lactamase inhibitor
Fig. 2 ESBL detection showing synergy towards cefepime and aztre‑
onam antibiotics disk
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